Deutsche Bank Aktiengesellschaft Downgrades Smith & Nephew (NYSE:SNN) to Hold

Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew (NYSE:SNN) from a buy rating to a hold rating in a research report released on Friday, MarketBeat.com reports.

Separately, StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Monday, August 5th. Two investment analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Smith & Nephew Price Performance

Shares of SNN stock traded up $0.15 during trading on Friday, reaching $25.24. 1,070,064 shares of the company’s stock traded hands, compared to its average volume of 799,524. The firm’s 50-day moving average is $29.98 and its 200 day moving average is $27.79. Smith & Nephew has a 1 year low of $23.24 and a 1 year high of $31.72. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.

Hedge Funds Weigh In On Smith & Nephew

A number of large investors have recently modified their holdings of SNN. River Road Asset Management LLC bought a new stake in Smith & Nephew during the third quarter valued at $38,588,000. Bank of Montreal Can grew its holdings in shares of Smith & Nephew by 355.8% during the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock worth $31,059,000 after purchasing an additional 964,762 shares in the last quarter. Brandes Investment Partners LP increased its position in shares of Smith & Nephew by 20.5% in the second quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock worth $34,002,000 after purchasing an additional 233,293 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Smith & Nephew by 58.2% in the second quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock valued at $12,995,000 after purchasing an additional 193,046 shares in the last quarter. Finally, Tocqueville Asset Management L.P. lifted its position in Smith & Nephew by 294.9% during the first quarter. Tocqueville Asset Management L.P. now owns 224,441 shares of the medical equipment provider’s stock valued at $5,692,000 after purchasing an additional 167,599 shares during the last quarter. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.